These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9131694)

  • 1. Barrier technology for TPN compounding; advantages and limitations.
    Lee MG
    Nutrition; 1997 Mar; 13(3):245-6. PubMed ID: 9131694
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary on the USP's proposed microbial limits for aseptic processing areas.
    Agalloco J; Akers J
    J Parenter Sci Technol; 1991; 45(1):1. PubMed ID: 2007964
    [No Abstract]   [Full Text] [Related]  

  • 3. Compounding TPN admixtures: then and now.
    Driscoll DF
    JPEN J Parenter Enteral Nutr; 2003; 27(6):433-8; quiz 439. PubMed ID: 14621126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aseptic methods for removing fluids from small-volume parenterals.
    Nagata RE; Mock ED; Reynolds G; Moriyama W; Schalker WL
    Hosp Pharm; 1977 Mar; 12(3):118-9, 122-6. PubMed ID: 10235811
    [No Abstract]   [Full Text] [Related]  

  • 5. Does your pharmacy have a compounding isolator?
    LaBella CJ
    Am J Health Syst Pharm; 2007 Apr; 64(8):855-8. PubMed ID: 17420203
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulatory aspects of isolation/barrier technology.
    Lyda JC
    PDA J Pharm Sci Technol; 1995; 49(6):300-4. PubMed ID: 8581462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Top ten hot topics in parenteral science and technology.
    Akers MJ; Nail SL; Saffell-Clemmer W
    PDA J Pharm Sci Technol; 2007; 61(5):337-61. PubMed ID: 18047174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extent of trace-element contamination from simulated compounding of total parenteral nutrient solutions.
    Pluhator-Murton MM; Fedorak RN; Audette RJ; Marriage BJ; Yatscoff RW
    Am J Health Syst Pharm; 1996 Oct; 53(19):2299-303. PubMed ID: 8893068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aseptic operation and control of ampul filling rooms.
    BREWER JH
    J Am Pharm Assoc Am Pharm Assoc; 1948 Oct; 37(10):415-20. PubMed ID: 18891120
    [No Abstract]   [Full Text] [Related]  

  • 10. Aseptic processing contamination case studies and the pharmaceutical quality system.
    Friedman RL
    PDA J Pharm Sci Technol; 2005; 59(2):118-26. PubMed ID: 15971544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parenteral nutrition in the Swiss hospitals: a three years national survey].
    Jetzer J; Maisonneuve N; Genton L; Mühlebach S; Pichard C
    Rev Med Suisse Romande; 2002 Jul; 122(7):333-7. PubMed ID: 12212489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk management, cGMP, and the evolution of aseptic processing technology.
    Agalloco J; Akers J; Baseman H; Boeh R; Madsen R; Ostrove S; Pavell A
    PDA J Pharm Sci Technol; 2009; 63(1):8-10. PubMed ID: 19455938
    [No Abstract]   [Full Text] [Related]  

  • 13. Selected ultratrace elements in total parenteral nutrition solutions.
    Berner YN; Shuler TR; Nielsen FH; Flombaum C; Farkouh SA; Shike M
    Am J Clin Nutr; 1989 Nov; 50(5):1079-83. PubMed ID: 2510493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small scale production of total parenteral nutrition infusions.
    Remon JP; De Rudder D
    J Clin Pharm Ther; 1989 Oct; 14(5):381-5. PubMed ID: 2511215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposal for a new categorization of aseptic processing facilities based on risk assessment scores.
    Katayama H; Toda A; Tokunaga Y; Katoh S
    PDA J Pharm Sci Technol; 2008; 62(4):235-43. PubMed ID: 19174952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choosing the appropriate membrane filter--test requirements.
    Jornitz MW; Meltzer TH; Bromm H; Priebe PM
    PDA J Pharm Sci Technol; 2005; 59(2):96-101. PubMed ID: 15971542
    [No Abstract]   [Full Text] [Related]  

  • 17. Early postoperative enteral nutrition improves gut oxygenation and reduces costs compared with total parenteral nutrition.
    Braga M; Gianotti L; Gentilini O; Parisi V; Salis C; Di Carlo V
    Crit Care Med; 2001 Feb; 29(2):242-8. PubMed ID: 11246300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achieving continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Badman C; Trout BL
    J Pharm Sci; 2015 Mar; 104(3):779-80. PubMed ID: 25501284
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preparation of intravenous hyperalimentation solution].
    Ogawa Y; Terada A
    Nihon Rinsho; 2001 May; 59 Suppl 5():206-14. PubMed ID: 11439522
    [No Abstract]   [Full Text] [Related]  

  • 20. [Validation of aseptic technique of parenteral nutrition compounding in a pharmacy service according to USP Chapter 797].
    Romero Jiménez RM; Pernía López MS; Sánchez Fresneda MN; Sanjurjo Sáez M
    Nutr Hosp; 2013; 28(5):1494-7. PubMed ID: 24160206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.